Makri E - Search Results

1

Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease.

Makri E, Cholongitas E, Tziomalos K. Makri E, et al. World J Gastroenterol. 2016 Nov 7;22(41):9039-9043. doi: 10.3748/wjg.v22.i41.9039. World J Gastroenterol. 2016. PMID: 27895393 Free PMC article.

2

Prevalence, etiology and management of non-alcoholic fatty liver disease in patients with polycystic ovary syndrome.

Makri E, Tziomalos K. Makri E, et al. Minerva Endocrinol. 2017 Jun;42(2):122-131. doi: 10.23736/S0391-1977.16.02564-5. Epub 2016 Oct 28. Minerva Endocrinol. 2017. PMID: 27792214 Free article. Review.

3

Arterial stiffness and peripheral arterial disease in patients with systemic lupus erythematosus.

Tziomalos K, Gkougkourelas I, Sarantopoulos A, Bekiari E, Makri E, Raptis N, Tselios K, Pantoura M, Hatzitolios AI, Boura P. Tziomalos K, et al. Among authors: makri e. Rheumatol Int. 2017 Feb;37(2):293-298. doi: 10.1007/s00296-016-3610-4. Epub 2016 Nov 21. Rheumatol Int. 2017. PMID: 27873008

4

Prevalence and geographic variation of abdominal obesity in 7- and 9-year-old children in Greece; World Health Organization Childhood Obesity Surveillance Initiative 2010.

Hassapidou M, Tzotzas T, Makri E, Pagkalos I, Kaklamanos I, Kapantais E, Abrahamian A, Polymeris A, Tziomalos K. Hassapidou M, et al. Among authors: makri e. BMC Public Health. 2017 Jan 28;17(1):126. doi: 10.1186/s12889-017-4061-x. BMC Public Health. 2017. PMID: 28129758 Free PMC article.

5

Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease.

Makri E, Goulas A, Polyzos SA. Makri E, et al. Arch Med Res. 2021 Jan;52(1):25-37. doi: 10.1016/j.arcmed.2020.11.010. Epub 2020 Dec 14. Arch Med Res. 2021. PMID: 33334622 Review.

6

Sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease.

Makri ES, Goulas A, Polyzos SA. Makri ES, et al. Eur J Pharmacol. 2021 Sep 15;907:174272. doi: 10.1016/j.ejphar.2021.174272. Epub 2021 Jun 17. Eur J Pharmacol. 2021. PMID: 34147478 Review.

7

Circulating adiponectin in patients with nonalcoholic fatty liver disease-related liver fibrosis: A systematic review and a meta-analysis.

Tontikidou C, Makri ES, Evripidou K, Goulis DG, Goulas A, Polyzos SA. Tontikidou C, et al. J Gastroenterol Hepatol. 2022 Oct;37(10):1853-1864. doi: 10.1111/jgh.15926. Epub 2022 Jul 15. J Gastroenterol Hepatol. 2022. PMID: 35748302

8

Combination Therapies for Nonalcoholic Fatty Liver Disease.

Makri ES, Makri E, Polyzos SA. Makri ES, et al. Among authors: makri e. J Pers Med. 2022 Jul 18;12(7):1166. doi: 10.3390/jpm12071166. J Pers Med. 2022. PMID: 35887662 Free PMC article. Review.

9

Circulating leptin in patients with nonalcoholic fatty liver disease-related liver fibrosis: a systematic review and a meta-analysis.

Makri ES, Evripidou K, Polyzos SA. Makri ES, et al. J Gastroenterol Hepatol. 2024 May;39(5):806-817. doi: 10.1111/jgh.16480. Epub 2024 Jan 18. J Gastroenterol Hepatol. 2024. PMID: 38238084

10

Animal studies of sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease.

Makri ES, Makri E, Goulas A, Xanthopoulos K, Polyzos SA. Makri ES, et al. Among authors: makri e. Ann Gastroenterol. 2024 May-Jun;37(3):280-290. doi: 10.20524/aog.2024.0884. Epub 2024 Apr 30. Ann Gastroenterol. 2024. PMID: 38779641 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters